MLKL and neoplasm: Interestingly, patients with high MLKL were associated with worse survival rates; this result was not consistent with other malignancies, including PDA33, gastric cancer34, colon cancer35, ovarian cancer36, cervical cancer37, and breast cancer38 in which MLKL expression level was decreased in tumor tissues, and low MLKL was associated with worse survival rates in those cancers.